AgomAb Therapeutics NV American Depositary Shares Working Capital to Net Assets Ratio
AgomAb Therapeutics NV American Depositary Shares working capital to net assets ratio. AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Working Capital to Net Assets ratio of 84.1% as of March 2026. Working capital of $123.50 Million (current assets of $133.01 Million minus current liabilities of $9.51 Million) is measured against net assets of $146.93 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of AgomAb Therapeutics NV American Depositary Shares (2021–2025)
Working capital to net assets ratio of AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025. This chart shows how AgomAb Therapeutics NV American Depositary Shares's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 84.1%, reflecting working capital of $123.50 Million against net assets of $146.93 Million USD. Explore AGMB long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
AgomAb Therapeutics NV American Depositary Shares Working Capital to Net Assets Ratio by Year (2021–2025)
AgomAb Therapeutics NV American Depositary Shares working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is AgomAb Therapeutics NV American Deposita's balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 78.4% | $102.65 Million | $130.90 Million | $121.24 Million | $18.59 Million | ▼ -9.2 pp |
| 2024 | 87.6% | $164.72 Million | $188.08 Million | $173.84 Million | $9.13 Million | ▲ +2.7 pp |
| 2023 | 84.9% | $128.59 Million | $151.44 Million | $139.47 Million | $10.88 Million | ▲ +22.5 pp |
| 2022 | 62.4% | $41.37 Million | $66.25 Million | $71.08 Million | $29.72 Million | ▲ +13.5 pp |
| 2021 | 48.9% | $20.72 Million | $42.36 Million | $54.43 Million | $33.71 Million | — |